Login

Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia 00:00:00

Share On Facebook Share On Twitter

$4-bil market opportunity in dyskinesia

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Gold 79 Mines: Advancing Southwest U.S. Gold Exploration
00:10:00
Tenable CEO Amit Yoran discusses recent spy balloon incidents and advancements in AI on CNBC.
00:10:00
Argenica Therapeutics CEO Dr. Liz Dallimore Discusses Development Pathway of ARG-007 | Liz Dallimore, CEO , Argenica Therapeutics Ltd.
00:10:00
SRC Updates on Project CLEANS: 2019 Remediation Progress and 2020 Plans
00:10:00
Creating Vibrant Urban Destinations: CEO Discusses Future Workplaces and Brewery Project Transformation | Nicklas Lindberg, CEO, Echo Investment SA.
00:00:00
Dr. Denise Scots-Knight Chief Executive Officer, Mereo BioPharma Group
00:10:00
Martin Cabrera Jr.: Empowering the Latino Community Through Wealth Creation
00:10:00
Anora Q2 Results and Future Outlook with CEO Jacek Pastuszka and CFO Stein Eriksen | Jacek Pastuszka, CEO, Anora Group Oyj.
00:10:00
Smart Financial Tips for Medical Professionals by Kade Hammes | Kade Hammes, Founder, Storybook Financial.
00:10:00
DeepGreen: Harvesting Essential Metals from the Ocean Floor for a Sustainable Future
00:10:00
Webinar: Insights on Galan Lithium's Hombre Muerto West Project
00:10:00
Exploring Depths: A Conversation with Mark Heine, CEO of FUGRO | Mark Heine - Chief Executive Officer of Fugro

© 2026 Nehu